These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2160616)

  • 1. (+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.
    Reid J; Duker G; Almgren O; Nerme V
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):215-20. PubMed ID: 2160616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta 1- and beta 2-adrenoceptor affinity and beta 1-blocking potency of S- and R-metoprolol.
    Wahlund G; Nerme V; Abrahamsson T; Sjöquist PO
    Br J Pharmacol; 1990 Mar; 99(3):592-6. PubMed ID: 1970503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
    Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
    Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.
    Campbell TJ
    Br J Pharmacol; 1987 Mar; 90(3):593-9. PubMed ID: 3567463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
    Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ
    J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.
    Walter M; Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):159-75. PubMed ID: 6092972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of the human cardiac monophasic action potential by sotalol.
    Echt DS; Berte LE; Clusin WT; Samuelsson RG; Harrison DC; Mason JW
    Am J Cardiol; 1982 Nov; 50(5):1082-6. PubMed ID: 6127944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.
    Kaumann AJ; Lemoine H
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):27-39. PubMed ID: 2866449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands.
    Lathrop DA
    Can J Physiol Pharmacol; 1985 Dec; 63(12):1506-12. PubMed ID: 3830350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles.
    Ravens U; Schöpper HP
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):232-9. PubMed ID: 1692975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
    Mori K; Hara Y; Saito T; Masuda Y; Nakaya H
    Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
    Doggrell SA
    Chirality; 1993; 5(1):8-14. PubMed ID: 8095397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic effect of beta-adrenoceptor-blocking drugs in Purkinje fibres of guinea-pig hearts.
    Lemmens-Gruber R; Zilberszac A; Heistracher P
    Arch Int Pharmacodyn Ther; 1996; 331(1):46-58. PubMed ID: 8896710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.